Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma
This prospective study was to investigate the possible risk factors for the leakage of chemotherapeutic agent into the systemic circulation after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). Peripheral plasma concentrations of chemotherapeutic agents were determ...
Main Authors: | Ming-Yen Hsieh, Zu-Yau Lin, Su-Hwei Chen, Wan-Long Chuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-10-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X11001227 |
Similar Items
-
Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma
by: Ming-Lun Yeh, et al.
Published: (2015-02-01) -
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Chia-I. Lin, et al.
Published: (2011-12-01) -
Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01) -
Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
by: Inderpreet Grover, et al.
Published: (2014-10-01) -
Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma
by: Naoto Kawabe, et al.
Published: (2021-06-01)